parp inhibitors in metastatic breast cancer: where are we now?
Published 5 years ago • 86 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
3:52
benefits and challenges of using parp inhibitors to treat metastatic breast cancer
-
3:04
advances in parp inhibitor use for metastatic breast cancer
-
3:17
the future of parp inhibitors in metastatic breast cancer
-
1:08
using parp inhibitors to improve quality of life for patients with metastatic breast cancer
-
1:10
managing metastatic breast cancer and beyond using parp inhibitors
-
5:37
the potential of parp inhibitors for metastatic cancer
-
1:41
parp inhibitors are a promising alternative to chemotherapy for patients with metastatic brca1 a...
-
27:11
optimizing adjuvant treatment of early breast cancer: where are we today?
-
7:42
parp inhibitors in other subtypes of breast cancer
-
27:25
opportunities and challenges in early breast cancer: do parp inhibitors have a role?
-
3:31
distinguishing between parp inhibitors in breast cancer
-
6:05
mechanisms of resistance to parp inhibitor or platinum chemotherapy in brca1/2 mutated metastati...
-
1:13:00
expanding the benefits of parp inhibitors to more patients with breast cancer and earlier settings
-
24:56
gynecologic cancer education: parp inhibitor therapy
-
7:46
pi3k and parp inhibitors in hr metastatic breast cancer
-
9:19
emerging therapies in metastatic and triple-negative breast cancer
-
58:44
what’s new with parp inhibitors and ovarian cancer?
-
59:56
research update on metastatic breast cancer
-
4:10
the embraca trial for advanced breast cancer, a new parp inhibitor